These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 9604123

  • 1. The effect of age on the pharmacokinetics of valsartan.
    Sioufi A, Marfil F, Jaouen A, Cardot JM, Godbillon J, Ezzet F, Lloyd P.
    Biopharm Drug Dispos; 1998 May; 19(4):237-44. PubMed ID: 9604123
    [Abstract] [Full Text] [Related]

  • 2. An interaction study with cimetidine and the new angiotensin II antagonist valsartan.
    Schmidt EK, Antonin KH, Flesch G, Racine-Poon A.
    Eur J Clin Pharmacol; 1998 Feb; 53(6):451-8. PubMed ID: 9551704
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers.
    Iqbal M, Khuroo A, Batolar LS, Tandon M, Monif T, Sharma PL.
    Clin Ther; 2010 Mar; 32(3):588-96. PubMed ID: 20399995
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic and pharmacodynamic interaction of single oral doses of valsartan and furosemide.
    Bindschedler M, Degen P, Flesch G, de Gasparo M, Preiswerk G.
    Eur J Clin Pharmacol; 1997 Mar; 52(5):371-8. PubMed ID: 9272406
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic interaction between pitavastatin and valsartan: a randomized, open-labeled crossover study in healthy male Korean volunteers.
    Jung JA, Noh YH, Jin S, Kim MJ, Kim YH, Jung JA, Lim HS, Bae KS.
    Clin Ther; 2012 Apr; 34(4):958-65. PubMed ID: 22410289
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic interactions of valsartan and hydrochlorothiazide: an open-label, randomized, 4-period crossover study in healthy Egyptian male volunteers.
    Hedaya MA, Helmy SA.
    Clin Ther; 2013 Jun; 35(6):846-61. PubMed ID: 23795576
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.
    Kim JE, Ki MH, Yoon IS, Cho HJ, Kim RS, Tae Kim G, Kim DD.
    Clin Ther; 2014 Feb 01; 36(2):273-9. PubMed ID: 24529292
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.